Hiram Chee

Hiram is responsible for design and development. He has over 30 years of broad operations and management experience in the medical device industry. Previously, Hiram was a consultant for start-up medical device companies responsible for development of a variety of disposable and implantable devices from concept through clinical evaluations, manufacturing scale-up and commercialization. He was Chief Operating Officer at Tautona Group, LLC, a private equity fund and incubator focused on wound healing, reconstructive and aesthetic surgery. Hiram was Executive Vice President at Spinal Kinetics, Inc. a venture-backed company developing and commercializing implants for the spine where he led product development, manufacturing, quality assurance, regulatory, and clinical affairs. He was Entrepreneur-in-Residence at US Venture Partners where he developed novel product concepts and conducted investment diligence. Hiram was Vice President, Research and Development and Operations, at MicroHeart, a startup that developed devices and pharmaceuticals to treat cardiovascular disease, acquired by Boston Scientific. He was Vice President Peripheral Vascular and Vice President, Research and Development at Target Therapeutics, a publicly traded company that developed intravascular devices to treat stroke and diseases in remote areas of the body, acquired by Boston Scientific and later acquired by Stryker.

Hiram received a B.S. in Chemical Engineering from the University of California, San Diego and a Certificate in Biomedical Engineering from the University of California, Irvine. Hiram is named inventor in over 50 issued US patents.